Some more coverage by sites for neurology professionals....
https://www.neurologylive.com/clinical-focus/trofinetide-triumphs-phase-2-study-rett-syndrome
http://practicalneurology.com/neuro...cally-relevant-improvement-for-retts-syndrome
Ann: Neuren's Rett syndrome Phase 2 trial published in Neurology, page-12
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.08 |
Change
0.225(1.75%) |
Mkt cap ! $1.635B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.921M | 375.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 107 | $13.08 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.09 | 1298 | 6 |
View Market Depth
| Last trade - 13.19pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |